APP and early-onset autosomal dominant Alzheimer disease: In 2013, Heneka, Mt et al.[22] published the paper in Nature, titled “NLRP3 is activated in Alzheimer's disease and contributes to pathology in APP/PS1 mice”, which confirmed the involvement of NLRP3 in the onset of AD.